Genetic research
Breakthrough in Cancer Gene Therapy: Researchers Develop New Synthetic Nanocarrier for Targeted Therapy
A team of researchers from Northwestern University has made a significant breakthrough in the field of cancer gene therapy. They have developed a new synthetic nanocarrier, PPDP2, which can block the RAS signaling system, a key driver of pancreatic cancer. This nanocarrier, composed of poly(ethylene glycol)--poly(propylene sulfide)